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A 39-year-old woman (gravida-2, para-2) was presented with men-
orrhagia and anemia. Preoperative diagnosis by magnetic resonance im-
aging was a 5-cm myoma of the uterus and a 4-cm cystadenoma of the
right ovary. Intraoperative ﬁndings were signiﬁcant for an 8-cm uterus
and a 4-cm cyst of the right ovary, and total laparoscopic hysterectomy
and cystectomy of the right ovary were performed. The anterior wall
of the uterus was laparoscopically incised with an ultrasonic scalpel
(HARMONIC ACE®, Ethicon, United States) to be deformed for vaginal
removal. The total weight of the uterus was 190 g. Pathological diagnosisIntroduction
Preoperative differentiation of endometrial stromal sarcoma (ESS)
from myoma is challenged by the similarities in their clinical presenta-
tions and the unreliability of imaging studies. Often, ESS is diagnosed
postoperatively after laparoscopic power morcellation of a presumed
myoma (Amant et al., 2014; Park et al., 2011). In approximately 80%
of ESS cases diagnosed postoperatively after morcellation, preoperative
diagnosiswas either leiomyomaor adenomyosis (Park et al., 2011). Lap-
aroscopic morcellation of ESS with an electromechanical morcellator
can result in the dissemination of the tumor (Park et al., 2011; Badia
and Karini, 2010), but there has been no report of the spread of ESS
after morcellation with a single incision on the uterus using a harmonic
scalpel. Furthermore, if the ovaries are preserved at the time of the ini-
tial surgery, bilateral salpingo-oophorectomy (BSO) for recurrence is
recommended (Amant et al., 2014; Yoon et al., 2014), but the effect of
BSO for recurrent ESS has not been reported. Here, we present a case
where morcellation with a simple incision in total laparoscopic hyster-
ectomy for a presumed myoma led to the peritoneal dissemination of
ESS; and complete remission was achieved and laparoscopically
conﬁrmed after BSO for recurrent ESS.d Gynecology, Hyogo College of
3-8501, Japan.
. This is an open access article underwas ESS, formerly referred to as low-grade ESS, and serous cystadenoma
of the right ovary. Postoperative thoracic computed tomography (CT) re-
vealed no evidence of lung metastasis; thus, the ﬁnal diagnosis was ESS
stage IA, according to the International Federation of Gynecology and
Obstetrics (FIGO) staging for uterine sarcomas (2009).
Thewomanwas followedupby a gynecologic oncologist,with vaginal
ultrasound examination every 3 months and abdominal and thoracic CT
every 6 months. Twenty months after the initial surgery, routine thorac-
ic/abdominal/pelvic CT indicated the presence of multiple lung metasta-
ses (5 mm and 4 mm) and the absence of abdominal and pelvic disease,
and she underwent video-assisted thoracic surgery. Pathological exami-
nation of the partial pneumonectomy conﬁrmed the lung metastases
of ESS, and immunohistochemical examination showed positivity for es-
trogen receptor and progesterone receptor (Fig. 1). We recommended
BSO, to which she agreed after mature consideration, and four months
after the thoracic surgery, she underwent laparoscopic exploration and
BSO. Intraoperative ﬁndings were signiﬁcant for the disseminations of
tumor on the pelvic peritoneum (Fig. 2). Biopsy of the lesions and BSO
were performed, but the disseminations persisted. Pathological examina-
tion conﬁrmed the peritoneal dissemination of ESS.
Six months after the BSO surgery, laparoscopic exploration for the
assessment of castrationwas performed, which revealed disappearance
of peritoneal disseminations (Fig. 3). Thereafter, she has had no evi-
dence of disease for 22 months. She received nohormonal therapy, che-
motherapy, or radiotherapy throughout the entire course of her disease.Discussion
Our case illustrates that a single incision using a harmonic scalpel
could potentially lead to ESS dissemination which has been similarlythe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Fig. 1.Microscopic and immunohistochemical analysis of tissue obtained by partial pneumonectomy. A: hematoxylin and eosin stain (40×), B: hematoxylin and eosin stain (200×),
C: estrogen receptor (200×), D: progesterone receptor (200×).
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Karini, 2010). However, we cannot prove that morcellation was the
deﬁnite cause of dissemination of ESS in this case, for late recurrences
are common in ESS and for the fact that lung metastases were present.
Recurrences, which can occur in about one-third of patients with
early-stage disease, present most commonly in the abdomen and
lungs (Amant et al., 2014). However, considering the median time to
recurrence of 65 months in stage I disease (Amant et al., 2014) and
the relatively short time to recurrence in our case, morcellation may
have resulted in subsequent pelvic dissemination. Park et al. recently
reported that tumor morcellation in early-stage ESS was associated
with a higher rate of recurrence (31.4%) and a lower rate of 5-year
disease-free survival (58%) compared to the counterparts with no
morcellation (7.4% and 89%, respectively) (Park et al., 2011). Besides
some case reports (Badia and Karini, 2010), most studies do not
clearly state whether morcellation was performed with or without anFig. 2. Pelvic peritoneal disseminations. Occult recurrence was detected during
laparoscopic exploration.electromechanical morcellator (Park et al., 2011; Yoon et al., 2014).
Our case indicates that dissemination of ESS could result from a simple
incision on the uterus without a power morcellator.
Furthermore, our case shows the efﬁcacy of BSO for recurrent ESS.
In the setting of initial surgery, hysterectomy is the cornerstone of
treatment for ESS, but preservation of the ovaries remains controversial.
Ovarian preservation can be considered for young women because it
does not affect overall survival (Amant et al., 2014; Yoon et al., 2014;
Bai et al., 2014; Amant et al., 2009; Amant et al., 2007), while BSO is
associated with longer recurrence-free survival (Amant et al., 2014;
Bai et al., 2014; Beck et al., 2012). On the other hand, BSO has gained
consensus for recurrent ESS (Amant et al., 2014; Bai et al., 2014).
However, there has been no report that actually proves the efﬁcacy
of BSO. Our case is the ﬁrst report that conﬁrmed, by laparoscopic
second-look surgery, the complete remission after BSO for recurrent
ESS.Fig. 3. Disappearance of pelvic peritoneal disseminations 6 months after bilateral
salpingo-oophorectomy.
3K. Inoue et al. / Gynecologic Oncology Reports 11 (2015) 1–3Morcellation of ESS should be avoided, but inadvertent morcellation
of ESS can occur in the absence of reliable imaging modalities
for accurate preoperative diagnosis. Informed consent to the possi-
bility that uterine sarcomas including ESS could be diagnosed after
morcellation of presumably benign uterine tumors is important. When
ESS is diagnosed after laparoscopic surgery, consultationwith gynecolog-
ic oncologists is necessary for further observation and treatment. To avoid
iatrogenic malignant dissemination, vaginal morcellation in a pouch has
been employed (Giovanni et al., 2012). Furthermore, BSO for recurrent
disease might be effective in achieving complete remission.
In conclusion, an incision on the uterus using a harmonic scalpel
could cause peritoneal dissemination of ESS, and remission might be
achieved by BSO for recurrent ESS.
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